Related Experiment Video
Updated: Jun 9, 2026

10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.1K
Impact of Linker Composition on VHL PROTAC Cell Permeability
Yordanos Esubalew Abeje1, Lianne H E Wieske1, Vasanthanathan Poongavanam1
1Department of Chemistry─BMC, Uppsala University, Box 576, 75123 Uppsala, Sweden.
Journal of Medicinal Chemistry
|December 18, 2024
Summary
Designing cell-permeable von Hippel-Lindau (VHL) proteolysis targeting chimeras (PROTACs) is difficult. Linker design is key, favoring folded PROTACs with low polar surface area for enhanced cell permeability.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Drug Discovery
Background:
- Developing cell-permeable and orally bioavailable von Hippel-Lindau (VHL) proteolysis targeting chimeras (PROTACs) presents significant challenges due to their complex structures.
- PROTACs often fall outside the conventional limits of orally druggable chemical space.
Purpose of the Study:
- To investigate the impact of linker design on the cell permeability of VHL PROTACs.
- To identify structural features that correlate with enhanced passive cell permeability in VHL PROTACs.
Main Methods:
- Design and synthesis of nine novel VHL PROTACs with varying linker compositions.
- Determination of PROTAC solution conformations in nonpolar solvents using biophysical techniques.
- Correlation analysis between PROTAC conformation, polar surface area, and cell permeability.
Main Results:
- The linker component significantly influences the passive cell permeability of VHL PROTACs.
- High cell permeability is associated with PROTACs adopting folded conformations with low solvent-accessible 3D polar surface area in nonpolar environments.
- Intramolecular hydrogen bonds, NH-π, and π-π interactions stabilize low-polarity conformations, enhancing cell permeability.
Conclusions:
- PROTAC design for cell permeability should focus on linkers that enable shielding of polar surface areas, particularly within the VHL ligand, in nonpolar environments.
- Understanding conformational preferences and non-covalent interactions is crucial for optimizing PROTAC delivery and oral bioavailability.

